Diseases, Conditions, Syndromes

Study finds extragenital infections are underdiagnosed

An internship in summer 2018 under the auspices of UdeM's PREMIER program for excellence in medicine through introduction to research has culminated in the publication of an article in a scientific journal for undergraduate ...

Diseases, Conditions, Syndromes

Chlamydia, gonorrhea rates up among young women in the US

(HealthDay)—There has been an age shift in positivity for Chlamydia trachomatis and Neisseria gonorrhoeae among women, according to a study published online Aug. 20 in the American Journal of Preventive Medicine.

Immunology

Blockade at the receptor

When chlamydia attacks the human body, the immune system activates. But the bacteria are adapted to defend themselves. Scientists from Würzburg have deciphered new details of their strategy.

Diseases, Conditions, Syndromes

Study links high community sanitation coverage to lower risk of trachoma

A global study of water and sanitation coverage has found that community access to sanitation facilities exceeding 80 percent reduces rates of trachoma, a blinding eye disease caused by repeated infection with Chlamydia trachomatis. ...

Diseases, Conditions, Syndromes

Study: Site of first chlamydia exposure makes big difference

Exposing the gut to chlamydia protects against subsequent infection in the genital tract and other tissues, researchers from UT Health San Antonio discovered. Chlamydia is the nation's most common sexually transmitted disease ...

Diseases, Conditions, Syndromes

New chlamydia drug targets discovered using CRISPR and stem cells

Scientists at the Wellcome Trust Sanger Institute and their collaborators at the University of British Columbia have created an innovative technique for studying how chlamydia interacts with the human immune system.

page 1 from 3

Chlamydia trachomatis, an obligate intracellular human pathogen, is one of three bacterial species in the genus Chlamydia. C. trachomatis is a Gram-negative bacteria, therefore its cell wall components retain the counter-stain safranin and appear pink under a light microscope.

The inclusion bodies of Chlamydia trachomatis were first described in 1907, the Chlamydia trachomatis agent was first cultured in the yolk sacs of eggs by Feifan Tang et al in 1957.

Chlamydial infection. Advances in the diagnostic isolation of Chlamydia, including TRIC agent, from the eye, genital tract, and rectum.

C. trachomatis includes three human biovars:

Many, but not all, C. trachomatis strains have an extrachromosomal plasmid.

This text uses material from Wikipedia licensed under CC BY-SA